Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-09-001903
Filing Date
2009-02-27
Accepted
2009-02-26 18:35:34
Documents
12
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2190819z10-k.htm 10-K 1030980
2 EXHIBIT 10.47 a2190819zex-10_47.htm EX-10.47 10686
3 EXHIBIT 10.48 a2190819zex-10_48.htm EX-10.48 14201
4 EXHIBIT 10.49 a2190819zex-10_49.htm EX-10.49 2732
5 EXHIBIT 10.50 a2190819zex-10_50.htm EX-10.50 58372
6 EXHIBIT 10.51 a2190819zex-10_51.htm EX-10.51 46601
7 EXHIBIT 23.1 a2190819zex-23_1.htm EX-23.1 3054
8 EXHIBIT 31.1 a2190819zex-31_1.htm EX-31.1 7957
9 EXHIBIT 31.2 a2190819zex-31_2.htm EX-31.2 7995
10 EXHIBIT 32 a2190819zex-32.htm EX-32 6709
11 G655380.JPG g655380.jpg GRAPHIC 39818
12 G97151.JPG g97151.jpg GRAPHIC 58646
  Complete submission text file 0001047469-09-001903.txt   1326715
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30319 | Film No.: 09639185
SIC: 2834 Pharmaceutical Preparations